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ABSTRACT
Objective: To determine the variation in prevalence of temporomandibular disorders (TMD), other
side effects, and technical complications during 5 years of sleep apnea treatment with a mandibular
advancement device.
Materials and Methods: Forty patients diagnosed with obstructive sleep apnea received an
adjustable appliance at 70% of the maximum protrusion. The protrusion was then progressively
increased. TMD (diagnosed according to the Research Diagnostic Criteria for TMD), overjet, overbite,
occlusal contacts, subjective side effects, and technical complications were recorded before and a
mean of 14, 21, and 58 months after treatment and analyzed by the Wilcoxon test (P , .05).
Results: Fifteen patients still used the oral appliance at the 5-year follow-up, and no significant
variation in TMD prevalence was observed. Subjective side effects were common, and a significant
reduction was found in overjet, overbite, and in the number of occlusal contacts. Furthermore, the
patients made a mean of 2.5 unscheduled dental visits per year and a mean of 0.8 appliance
repairs/relines per year by a dental technician. The most frequent unscheduled visits were needed
during the first year and were a result of acrylic breakage on the lateral telescopic attachment, poor
retention, and other adjustments to improve comfort.
Conclusions: Five-year oral appliance treatment does not affect TMD prevalence but is
associated with permanent occlusal changes in most sleep apnea patients during the first 2
years. Patients seek several unscheduled visits, mainly because of technical complications. (Angle
Orthod 2010;80:30–36.)
KEY WORDS: Sleep-disordered breathing; Oral appliance; Craniomandibular disorders; Adverse
effects; Device failure
INTRODUCTION
Obstructive sleep apnea (OSA) is a common
respiratory disorder characterized by recurrent upper
airway obstruction during sleep. Treatment options for
OSA include behavioral modification, continuous pos-
itive airway pressure (CPAP), surgery, and oral
appliances. Although CPAP appears to be most
effective in improving OSA, oral appliances may be a
good alternative for patients with mild to moderate
symptoms who prefer oral appliances to CPAP or for
those who are unable to tolerate CPAP therapy.1
Mandibular advancement devices (MAD) are the
most common class of oral appliance used to treat
snoring and OSA. Although there are several MAD
designs, all devices protrude the mandible and induce
changes in the anterior position of the tongue, soft
palate, lateral pharyngeal walls, and mandible, result-
ing in improved airway patency.2 Increasing evidence
suggests that MAD improves sleep-disordered breath-
ing.1 However, response to MAD is variable and
normally depends on the MAD design and patient
characteristics. The acceptance rate of MAD after 1
year ranged from 55% to 82%, and there was a
declining trend over time.2 The most common reasons
a Associate Professor, Department of Prosthodontics, Faculty
of Dentistry, University of Barcelona, Barcelona, Spain.
b Medical Doctor, Sleep Unit, Respiratory Department, Bell-
vitge University Hospital, L’Hospitalet de Llobregat, Barcelona,
Spain.
c Medical Doctor, CIBER respiratory diseases and IDIBELL,
Sleep Unit, Respiratory Department, Bellvitge University Hospi-
tal, L’Hospitalet de Llobregat, Barcelona, Spain.
Corresponding author: Dr Jordi Martı´nez-Gomis, Department
of Prosthodontics, Faculty of Dentistry, University of Barcelona,
Campus de Bellvitge, C/ Feixa llarga s/n, L’Hospitalet de
Llobregat, Barcelona 08907, Spain
(e-mail: jmartinezgomis@ub.edu)
Accepted: April 2009. Submitted: March 2009.
G 2010 by The EH Angle Education and Research Foundation,
Inc.
DOI: 10.2139/030309-122.130Angle Orthodontist, Vol 80, No 1, 2010
for discontinuing MAD use are lack of efficacy, side
effects, and complications.3
Subjective side effects are common, and the most
frequently reported include temporomandibular joint
(TMJ) pain, myofascial pain, tooth pain, salivation,
TMJ sounds, dry mouth, gum irritation, and morning-
after occlusal changes.4–7 Most of these side effects
are minor and well-tolerated and tend to be resolved in
a short period. However, objective side effects such as
tooth movement, skeletal changes, and occlusal
alteration have also been reported.5,8–17 Temporoman-
dibular disorders (TMD) have been associated with the
use of MAD, and this disorder is one of the exclusion
criteria for many clinical studies. The majority of
studies used the Helkimo Index or signs and symp-
toms to assess TMD.9,16,18 TMD are a cluster of
heterogeneous disorders of the masticatory muscles
and TMJs. The myogenous and arthrogenous disor-
ders may be further subclassified into myofascial and
arthrogenous pain, disc displacements, and degener-
ative joint disease as the most common conditions.
The Research Diagnostic Criteria for TMD (RDC/TMD)
were developed for research use and are a successful
diagnostic and classification system.19
Appliances are usually worn every night indefinitely
for symptomatic relief. The type and frequency of
technical complications of MADs should be considered
before treatment. However, technical complications
with MADs, such as clasp breakages, repeated
adjustments to optimize retention, or replacement of
the device, have been reported in only a few stud-
ies.4,11,18,20,21 Technical complications may affect the
cost for the patient and compliance with the treatment.22
The aim of this study was to evaluate variations in
prevalence of TMD in OSA patients, as well as other
side effects and technical failures, during 5 years of
use of MADs.
MATERIALS AND METHODS
Forty-one adult patients with mild to severe OSA
were recruited from the Sleep Unit of the Bellvitge
University Hospital, Barcelona, Spain, between April
2002 and May 2004. All patients were diagnosed with
OSA, based on the presence of OSA symptoms
(snoring, apnea, and sleepiness) and overnight poly-
somnography (Apnea-Hypopnea Index . 10/h). Poly-
somnography was scored manually according to
standard criteria.23 Patients were excluded if severe
periodontal disease was present or if there were
insufficient teeth to fit the MAD. All patients gave
written informed consent to participate in the study,
which was approved by the ethics committee of
Bellvitge University Hospital. One patient was exclud-
ed because he did not have the minimum number of
healthy teeth needed to retain the oral appliance.
Therefore, 40 OSA patients participated in this
prospective case series.
The MAD consisted of two full-coverage acrylic
splints connected by two lateral telescopic attach-
ments (Herner Guiding Telescopes, Iserlohn, Ger-
many), allowing mouth breathing and a degree of side-
to-side, protrusive, and opening movements of the
mandible. Polyvinylsiloxane impressions of the maxil-
lary and mandibular arches were used to manufacture
dental plaster casts. The George Gauge (Great Lakes
Orthodontic Lab, Tonowanda, NY) was used to
measure the maximum mandibular protrusion capacity
and then to make an interocclusal record of the desired
anteroposterior and vertical mandibular position to be
achieved by the MAD. The amount of mandibular
advancement was initially set at 70% of the maximum
and was then progressively increased over the
following weeks until the patient stopped snoring or
side effects appeared. All MADs were fabricated by the
same dental technician and fitted and adjusted by a
specialist dentist. The patients were instructed to use
the MAD every night during sleep.
Before treatment was initiated, one dental clinician
examined all patients, applied the RDC/TMD, and
recorded the occlusal characteristics. Following the
RDC/TMD algorithms, all subjects were assigned to
the non-TMD group or to one of the three main groups
(group I, myofascial pain; group II, TMJ disc displace-
ment; group III, TMJ arthralgia/osteoarthritis/osteoar-
throsis).19 Multiple diagnoses per subject were also
possible. Overjet and overbite were measured by
means of a digital caliper (Absolute; Vogel Germany,
Kevelaer, Germany). Intraoral tooth contact in the
intercuspal position was recorded using occlusal
registration strips (Bausch Articulating Paper, Ko¨ln,
Germany), and the recording was drawn on the
protocol sheet.24 The number of occlusal contacts
and the number of teeth in contact were recorded in
both the anterior and posterior regions.
The follow-up visits were planned to be performed 6
weeks after the last increase in mandibular advance-
ment, 6 months later, and 5 years after starting the
therapy. The first checkup visit was performed after an
average of 14 months from the start of treatment, the
second checkup was performed after an average of 21
months from the start of treatment, and the third
checkup took place after 4.8 years (range, 3.6 to 5.8
years). Follow-up visits consisted of occlusal registra-
tion, application of the RDC/TMD protocol, and a
questionnaire to record the side effects reported by the
patients. When patients referred to TMD-related
symptoms, the RDC/TMD protocol was performed
again. To evaluate the MAD treatment outcome,
polysomnography was repeated close to the time of
COMPLICATIONS DURING APNEA TREATMENT 31
Angle Orthodontist, Vol 80, No 1, 2010
the first checkup for patients wearing the oral
appliance during the night. Patients whose polysom-
nographs showed a lack of response were advised to
discontinue MAD use.
During the treatment, patients with technical com-
plications of the MAD and side effects involving the
masticatory system were seen by a dentist. The
number of additional dental visits, the reason for each
extra visit, and the number of MAD repairs in the dental
laboratory were recorded. Routine checkups and visits
to increase the amount of mandibular advancement
were excluded from this analysis.
Occlusal characteristics, TMD prevalence, and
subjective side effects data at baseline and at each
follow-up were compared using the Wilcoxon test for
paired samples. P , .05 was regarded as statistically
significant.
RESULTS
Thirty-one men and nine women were included in
the study. The mean age was 54.1 years (SD 8.7;
range, 35 to 70). Of these 40 patients, five did not
attend the first checkup, four were lost, and another
patient was affected by repetitive acrylic breakages on
the lateral telescopic attachment of the oral appliance.
This patient was included in the technical complica-
tions analysis but not in the side effects analysis.
Between the first and the second checkup, 17 patients
stopped using the MAD, 11 of them because poly-
somnography showed that it was ineffective, three
because of side effects (arthralgia, myofascial pain, or
discomfort), and the other three because it was
considered that the appliance was no longer neces-
sary, oral cancer, or dental modifications. Between the
second and third checkups, three more patients were
excluded: one because of multiple breakages, the
second because of discomfort, and the third because
he lost weight and the MAD was no longer needed.
Therefore, 15 patients still used the MAD at the 5-year
checkup. The mean mandibular advancement at the
first checkup was 9.4 mm (83% of the maximum
protrusion), and an increase in vertical dimension of
9.2 mm was observed at the incisal level.
At baseline, 10 patients were diagnosed with TMD
according to the RDC/TMD (Table 1). Of these, three
were classified as presenting myofascial pain (group I),
seven presented disc displacement with reduction
(group II), and two presented arthralgia (group III).
Two patients diagnosed as belonging to group II were
also diagnosed as belonging to either group I or group
III, given that the diagnostic groups were not mutually
exclusive. Three of the five patients initially diagnosed
as disc displacement with reduction still used the MAD
at the 5-year follow-up, and only one of these patients
was still diagnosed as disc displacement. Two patients
who were initially diagnosed as disc displacement and
five initially diagnosed as myofascial pain or arthralgia
stopped using the MAD because it was ineffective,
rather than as a result of problems with the masticatory
system. No significant differences were observed in
the prevalence of any TMD diagnosis group before
treatment and at each checkup. During advancement
of MAD, four patients reported mandibular pain. Three
of these cases were diagnosed as arthralgia and the
other as myofascial pain. Two of these four patients
had not been diagnosed with TMD at baseline.
The number of occlusal contacts on the posterior
teeth was reduced significantly during the 5 years of
MAD treatment, and the greatest reduction was
observed at the second checkup (Table 2). No
significant differences in occlusal contacts or in the
number of teeth in contact in the anterior region were
observed during MAD treatment (Figure 1). Overbite
and overjet were also significantly reduced during all
treatments. Only 9%, 28%, and 33% of patients
reported no side effects at the first, second, and last
checkups, respectively (Table 3). Four patients
stopped using the MAD because of side effects. The
percentage of patients who reported tooth discomfort
or mucosal irritations was significantly lower at the last
checkup than at the first checkup.
Table 1. Number (Percentage) of Patients Diagnosed with Temporomandibular Disorders (TMD) for Each Diagnosis Group According to RDC/





































N 5 40 N 5 35 N 5 18 N 5 15 N 5 35 N 5 18 N 5 15 N 5 18 N 5 15 N 5 15
TMD (any group) 10 (25%) 9 (26%) 3 (17%) 3 (20%) 7 (20%) 2 (11%) 2 (13%) 1 (6%) 1 (7%) 1 (7%)
Group I Myofascial pain 2 (5%) 1 (3%) 0 (0%) 0 (0%) 1 (3%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Group II Disc displace-
ment 7 (18%) 7 (20%) 3 (17%) 3 (20%) 5 (14%) 2 (11%) 2 (13%) 1 (6%) 1 (7%) 1 (7%)
Group III Arthralgia 3 (8%) 3 (9%) 0 (0%) 0 (0%) 1 (3%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
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Only eight patients did not request an extra visit to the
dentist; four of these still used the MAD at the 5-year
checkup. During the observational period, the patients
made 160 extra visits to the dentist, and 54 appliance
modifications were performed by the dental technician
(Table 4). This corresponds to a mean of 2.5 unsched-
uled dental visits per year and a mean of 0.8 appliance
repairs/relines per year by a dental technician. The most
frequent unscheduled visits were needed during the first
year because of acrylic breakage on the lateral
telescopic attachment (Figure 2), poor retention, and
other adjustments to improve comfort. Forty appliance
repairs (32 because of acrylic breakage and eight relines
because of MAD loosening) were made by the dental
technician during the first 14 months.
DISCUSSION
The results of the present study confirm the
reduction of overbite and overjet associated with the
use of MAD reported in other long-term follow-up
studies.13,14 Furthermore, the number of posterior
occlusal contacts and number of posterior teeth in
contact were significantly reduced during the first 2
years of MAD use. However, this tendency reversed
during the period of 2 to 5 years of treatment, in
Figure 1. Individual number of occlusal contacts in the posterior
teeth (n 5 15) at baseline and at each checkup.





































N 5 40 N 5 35 N 5 18 N 5 15 N 5 35 N 5 18 N 5 15 N 5 18 N 5 15 N 5 15
Posterior OCa 14.8 (6) 14.1 (6) 16.4 (6) 16.6 (6) 11.6 (7)** 13.1 (7)* 11.7 (7)** 11.5 (8)** 10.7 (8)** 12.7 (8)*
Anterior OC 6.4 (2) 6.5 (2) 6.3 (2) 6.5 (2) 6.5 (2) 6.3 (2) 6.1 (2) 6.8 (2) 6.6 (2) 6.9 (2)
Posterior TIC 6.4 (2) 6.4 (2) 7.1 (2) 7.0 (2) 5.6 (3)* 6.1 (3)* 5.5 (3)** 5.9 (3)* 5.5 (3)** 6.1 (2)
Anterior TIC 5.1 (1) 5.1 (1) 5.2 (1) 5.3 (1) 5.0 (1) 4.9 (1) 4.9 (1) 5.1 (1) 5.1 (1) 5.5 (1)
Overbite (mm) 2.69 (2) 2.71 (2) 3.40 (2) 3.35 (2) 2.20 (2)** 2.82 (2)* 2.77 (2)* 2.83 (2)* 2.63 (2)* 2.54 (3)*
Overjet (mm) 2.87 (2) 2.82 (2) 3.28 (2) 3.07 (2) 1.99 (2)*** 2.53 (3)** 2.31 (2)* 2.54 (3)* 2.22 (2)* 1.97 (2)**
a OC indicates number of occlusal contacts; TIC, number of teeth in contact.
*P , .05; **P , .01; ***P , .001, with respect to the baseline value (Wilcoxon test) for each group of patients.
Table 3. Number of Patients (Percentage) Who Reported Side Effects Related to the Use of the Oral Appliance at Each Follow-Up















N 5 35 N 5 18 N 5 15 N 5 18 N 5 15 N 5 15
At least 1 side effect 32 (91%) 16 (89%) 13 (87%) 13 (72%) 10 (67%) 10 (67%)
Dry mouth 15 (43%) 5 (28%) 3 (20%) 5 (28%) 3 (20%) 1 (7%)
Excessive salivation 17 (49%) 11 (61%) 10 (67%) 7 (39%)* 7 (47%) 8 (53%)
TMJ discomfort or pain 9 (26%) 4 (22%) 4 (27%) 0 (0%)* 0 (0%)* 1 (7%)
Tooth discomfort or pain 16 (46%) 11 (61%) 10 (67%) 7 (39%) 6 (40%) 2 (13%)*
Muscular discomfort 4 (11%) 2 (11%) 2 (13%) 1 (6%) 1 (7%) 2 (13%)
TMJ sounds 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (7%)
Mouth opening limitation 1 (3%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Bite change 9 (26%) 3 (17%) 2 (13%) 3 (17%) 2 (13%) 1 (7%)
Mucosal irritations 12 (34%) 7 (39%) 6 (40%) 3 (17%) 1 (7%)* 1 (7%)*
*P , .05; with respect to the first checkup value (Wilcoxon test) for each group of patients.
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agreement with another long-term study.8 It has been
reported that the occlusal contact area and bite force
of patients were reduced in the first months of wearing
MAD.15 This was also demonstrated in a long-term
study.17 Since bite force and occlusal contact area are
the main factors that explain masticatory performance
in dentate subjects,25 and the asymmetry of these
factors is related to masticatory laterality,26 it appears
that a reduction in masticatory performance can be
expected in these patients. However, a direct relation-
ship between the use of MAD and a worsening of
masticatory efficiency is not demonstrated; this could
be the subject of further research.
The results of this study suggest that 5 years of MAD
treatment did not modify TMD prevalence in OSA
patients. This is the first study in which TMD was
diagnosed according to the RDC/TMD and classified
as myofascial pain, disc displacement, and TMJ
arthralgia/arthrosis in OSA patients in long-term
therapy with MAD. Furthermore, OSA patients initially
diagnosed with TMD were not excluded from this
study. Although it has been stated that active TMD is a
contraindication for MAD treatment,27 the results of this
study, in agreement with other studies,9,10,16 suggest
that the presence of disc displacement with reduction
in the TMJ may not be a contraindication to treatment
with a MAD. Furthermore, it has been found by means
of magnetic resonance imaging that MAD appears to
be innocuous to the TMJ in OSA patients, even in
those with anterior disc displacement with or without
reduction.28 The onset of arthrogenous or myogenous
pain during advancement of MAD does not seem to be
related to the presence of TMD before treatment.
We observed that MAD breakages, mainly on the
lateral telescopic attachment, were the most frequent
reason for seeking an unscheduled visit to the dentist.
Such complications could be explained by errors made
by the technician, maladjustments made by the dentist,
and functional overload caused by nocturnal bruxism.
These complications not only led to discontinuation of
the use of MAD in two patients but also increased the
cost of treatment and delayed effective treatment for
OSA. Therefore, technicians and dentists should make
the maximum effort to give patients the most comfort-
able and robust appliance. Although many studies
have been published about the efficacy and side
effects of MAD therapy, only a few reports have dealt
with technical failure and the maintenance costs of
these devices.4,11,18,20–22 In a previous study, 60% of
subjects had experienced Herbst breakage and 40%
received a replacement appliance after 3.6 years of
treatment.11 When a monoblock MAD was used,
technical complications were reported infrequently
during the first year of treatment.18 However, six of
nineteen patients had their monoblock device replaced
by a new one in a 5-year follow-up study.20 Monoblock
devices could be more robust and cost effective, but
an adjustable appliance allows the mandible to be
protruded incrementally and permits a degree of side-
to-side, protrusion, and opening movement of the
mandible.
Table 4. Number of Additional Visits with the Corresponding Reason and the Number of Appliance Repairs During Oral Appliance Treatment









All Patients Users at First Checkup Users at Second Checkup Users at Third Checkup
N 5 36 N 5 36 N 5 18 N 5 15
Mean time (mo) 34 13.6 10.1 35
Clinical adjustment 14 13 0 1
MAD breakages 96 71 10 15
MAD loosening 22 19 2 1
Side effects, other 28 20 0 8
Total clinical extra visits (extra visits/
patient/year) 160 (2.5) 123 (3.0) 12 (0.7) 25 (0.6)
Number of repairs at laboratory
(number/patient/year) 54 (0.8) 40 (0.9) 6 (0.4) 8 (0.2)
Figure 2. Acrylic breakage on the lateral telescopic attachment.
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The present study has several limitations. First, no
control group was used, and a cause-and-effect
relationship between the results of the present study
and the use of MAD should be assumed with caution.
Furthermore, we cannot know whether some adverse
effects were related to the use of an intraoral appliance
and/or to fact that the jaw was protruded for 6 to 8 hours
per day. Second, the sample size might not have been
large enough to find significant comparisons or relation-
ships, such as in the prevalence of TMD.
CONCLUSIONS
N In most OSA patients, 5-year oral appliance treat-
ment is associated with mild, temporary subjective
side effects and permanent occlusal changes mainly
during the first 2 years.
N The use of the oral appliance does not affect TMD
prevalence.
N Patients often seek several unscheduled visits,
mainly because of technical complications.
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